- From: Andrea Splendiani (RRes-Roth) <andrea.splendiani@rothamsted.ac.uk>
- Date: Thu, 22 Dec 2011 15:41:24 +0000
- To: "Waard, Anita de A (ELS-NYC)" <A.dewaard@elsevier.com>
- CC: Oliver Ruebenacker <curoli@gmail.com>, public-semweb-lifesci <public-semweb-lifesci@w3.org>
Hi, It would be interesting to setup a list of companies which makes a mission-critical use of semantic-web technologies. This could start to be some good evidence on the impact of these technologies. Does anybody knows if such a list exists ? STI people have a list of Semantic Web companies, but I was thinking about something smaller and more focused. best, Andrea Il giorno 22/dic/2011, alle ore 15.25, Waard, Anita de A (ELS-NYC) ha scritto: > Oliver, > > Elsevier uses semantic technologies (i.e. OWL ontologies, a Linked Data Repository, metadata in RDF) throughout all of our content management, search and annotation systems. If OWL/RDF were to evaporate tomorrow, our products (including the Cell and other cell biology publications) wouldn't work - it's as simple as that. Is that enough evidence? Let me know if you need something more formal. > > Best, > > - Anita. > > Anita de Waard > Disruptive Technologies Director, Elsevier Labs > http://elsatglabs.com/labs/anita/ > a.dewaard@elsevier.com > > > > -----Original Message----- > From: Andrea Splendiani (RRes-Roth) [mailto:andrea.splendiani@rothamsted.ac.uk] > Sent: Thu 12/22/2011 10:09 > To: Oliver Ruebenacker > Cc: public-semweb-lifesci > Subject: Re: Evidence of Significance of Semantic Web for Life Sciences > > Hi Oliver, > > I think it's hard to find this form of "breakthrough evidence" and this may even be counterproductive to convince people. > If you present a high-level, breakthrough result (say, we save lives), than you leave two open questions: > - how much of this is dependent on the computational support ? > - ok, they used semantic web technologies, could we use something else ? > > Another way to go would be to measure results over resources (benefits is economic) or adoption (benefit is potential for economies of scale). > There is a wide range of sources to cite about this out of the biomedical world, from companies to governments. > > Look for "Biomedical Semantics in the Semantic Web" in JBS, we write something about adoption, you may find some link/inspiration there. > > ciao, > Andrea > > > > > Il giorno 21/dic/2011, alle ore 16.39, Oliver Ruebenacker ha scritto: > >> Hello, >> >> I am looking for evidence I can quote to convince non-experts of the >> significance of applying Semantic Web to biomedical research, >> especially computational cell biology. >> >> I need a recorded public statement from a source recognizable as >> authoritative to a non-expert: e.g. could be from a relevant >> government agency, a well-known research institution (including major >> grad schools and companies), a well-known (i.e. well-known outside the >> field) expert, some one where a brief look at the biography >> immediately suggests he or she is an authority, some one quoted in >> major media, etc. >> >> Significance could mean abstract things like advancing science and >> health care, but even better would be tangible things like: saves >> lives, saves money, cures cancer/malaria/AIDS, creates jobs, etc. >> >> Thanks a lot! >> >> Take care >> Oliver >> >> -- >> Oliver Ruebenacker, Computational Cell Biologist >> Virtual Cell (http://vcell.org) >> SBPAX: Turning Bio Knowledge into Math Models (http://www.sbpax.org) >> http://www.oliver.curiousworld.org >> > > > > Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, Registration No. 33156677 (The Netherlands) >
Received on Thursday, 22 December 2011 15:42:10 UTC